Safeguarding immune globulin recipients against hemolysis: what do we know and where do we go?
Transfusion
.
2015 Jul:55 Suppl 2:S122-6.
doi: 10.1111/trf.13196.
Authors
Dorothy E Scott
1
,
Jay S Epstein
1
Affiliation
1
Office of Blood Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
PMID:
26174890
DOI:
10.1111/trf.13196
No abstract available
Publication types
Review
MeSH terms
ABO Blood-Group System*
Hemolysis / drug effects*
Humans
Immunoglobulins, Intravenous / adverse effects*
Immunoglobulins, Intravenous / therapeutic use
Substances
ABO Blood-Group System
Immunoglobulins, Intravenous